Alpha DNA Investment Management LLC Makes New $719,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alpha DNA Investment Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,463 shares of the medical equipment provider’s stock, valued at approximately $719,000.

Other hedge funds have also recently made changes to their positions in the company. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after purchasing an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares during the last quarter. Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Finally, Swiss National Bank increased its stake in Intuitive Surgical by 0.3% in the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after purchasing an additional 3,400 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,935 shares of company stock valued at $26,305,169 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Wells Fargo & Company upped their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $524.61.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $547.87 on Friday. The firm’s 50-day moving average price is $504.73 and its 200-day moving average price is $463.54. The company has a market capitalization of $195.14 billion, a PE ratio of 88.08, a P/E/G ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.